Sumitomo Pharma Revenue

In the fiscal year ending March 31, 2025, Sumitomo Pharma had annual revenue of 398.83B JPY with 26.79% growth. Sumitomo Pharma had revenue of 105.65B in the quarter ending March 31, 2025, with 32.84% growth.

Revenue

398.83B JPY

Revenue Growth

+26.79%

P/S Ratio

0.88

Revenue / Employee

80.09M JPY

Employees

4,980

Market Cap

2.33B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%
Mar 31, 2021	515.95B	33.22B	6.88%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.73B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Glass House Brands	200.90M
Elite Pharmaceuticals	70.00M
Northwest Biotherapeutics	1.38M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings